相关实验视频
Updated: Sep 19, 2025

11:31
Evaluation of the Storage Stability of Extracellular Vesicles
Published on: May 22, 2019
14.4K
动脉样硬化的细胞外囊泡来源的多样性:作用和治疗应用
Yuan Zhang1,2, Wendiao Zhang3,4, Zhiwen Wu1,2
1School of Pharmacy, Nanchang University, Nanchang, 330006, Jiangxi, People's Republic of China.
Angiogenesis
|June 16, 2025
概括
细胞外囊泡 (EVs) 在细胞通信和心血管疾病 (CVD),如动脉样硬化 (AS) 中至关重要. 本综述详细介绍了EV隔离和生成方法,用于研究AS病原和开发生物标志物.
科学领域:
- 生物化学 生化学
- 细胞生物学 细胞生物学
- 心血管研究研究心血管研究
背景情况:
- 细胞外囊泡 (EVs) 是细胞分泌的结构,对细胞间通信和恒温至关重要.
- 功能失调的EV越来越多地与心血管疾病 (CVD) 相关,特别是动脉样硬化 (AS).
研究的目的:
- 审查当前用于隔离和生成AS研究的EV的方法.
- 提供关于使用电动汽车用于AS疾病和功能研究的见解.
- 突出显示EVs作为潜在的诊断生物标志物和AS的治疗目标.
主要方法:
- 关于电动汽车隔离和发电技术的文献综述.
- 分析了在AS中使用来自不同细胞类型和疾病模型的EV的研究.
- 对电动汽车应用的工程策略汇编,用于AS机制阐明.
主要成果:
- 包括外体体,微体和亡体在内的EVs是AS病变的关键参与者.
- 电动汽车的工程策略为研究AS机制提供了新的途径.
- 来自不同来源的电动汽车为AS开发提供了宝贵的见解.
结论:
- 电动汽车为了解AS复杂的病因提供了一种新的方法.
- 需要标准化的EV方法来进行可靠的in-vivo签名总结.
- 电动汽车在AS生物标志物发现和治疗开发方面具有重大潜力.
更多相关视频
07:03Isolation, Characterization, and Therapeutic Application of Extracellular Vesicles from Cultured Human Mesenchymal Stem Cells
Published on: September 23, 2022
2.2K
05:30Author Spotlight: Advancing the Analysis of Plasma Extracellular Vesicle Proteome for Cardiovascular Biomarker Studies
Published on: January 31, 2025
622
相关概念视频
Overview of Exosomes
2.9K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.9K
Atherosclerosis III: Management
42
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
42